Ursus arctos (brown bear): 113262259
Help
Entry
113262259 CDS
T05909
Symbol
CASP3
Name
(RefSeq) caspase-3 isoform X3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
uah
Ursus arctos (brown bear)
Pathway
uah01524
Platinum drug resistance
uah04010
MAPK signaling pathway
uah04115
p53 signaling pathway
uah04148
Efferocytosis
uah04210
Apoptosis
uah04215
Apoptosis - multiple species
uah04623
Cytosolic DNA-sensing pathway
uah04650
Natural killer cell mediated cytotoxicity
uah04657
IL-17 signaling pathway
uah04668
TNF signaling pathway
uah04726
Serotonergic synapse
uah04932
Non-alcoholic fatty liver disease
uah04933
AGE-RAGE signaling pathway in diabetic complications
uah04936
Alcoholic liver disease
uah05010
Alzheimer disease
uah05012
Parkinson disease
uah05014
Amyotrophic lateral sclerosis
uah05016
Huntington disease
uah05020
Prion disease
uah05022
Pathways of neurodegeneration - multiple diseases
uah05132
Salmonella infection
uah05133
Pertussis
uah05134
Legionellosis
uah05145
Toxoplasmosis
uah05146
Amoebiasis
uah05152
Tuberculosis
uah05160
Hepatitis C
uah05161
Hepatitis B
uah05162
Measles
uah05163
Human cytomegalovirus infection
uah05164
Influenza A
uah05165
Human papillomavirus infection
uah05167
Kaposi sarcoma-associated herpesvirus infection
uah05168
Herpes simplex virus 1 infection
uah05169
Epstein-Barr virus infection
uah05170
Human immunodeficiency virus 1 infection
uah05200
Pathways in cancer
uah05203
Viral carcinogenesis
uah05205
Proteoglycans in cancer
uah05206
MicroRNAs in cancer
uah05210
Colorectal cancer
uah05222
Small cell lung cancer
uah05416
Viral myocarditis
uah05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
uah00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
113262259 (CASP3)
04668 TNF signaling pathway
113262259 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
113262259 (CASP3)
09143 Cell growth and death
04210 Apoptosis
113262259 (CASP3)
04215 Apoptosis - multiple species
113262259 (CASP3)
04115 p53 signaling pathway
113262259 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
113262259 (CASP3)
04650 Natural killer cell mediated cytotoxicity
113262259 (CASP3)
04657 IL-17 signaling pathway
113262259 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
113262259 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
113262259 (CASP3)
05206 MicroRNAs in cancer
113262259 (CASP3)
05205 Proteoglycans in cancer
113262259 (CASP3)
05203 Viral carcinogenesis
113262259 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
113262259 (CASP3)
05222 Small cell lung cancer
113262259 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
113262259 (CASP3)
05161 Hepatitis B
113262259 (CASP3)
05160 Hepatitis C
113262259 (CASP3)
05164 Influenza A
113262259 (CASP3)
05162 Measles
113262259 (CASP3)
05168 Herpes simplex virus 1 infection
113262259 (CASP3)
05163 Human cytomegalovirus infection
113262259 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
113262259 (CASP3)
05169 Epstein-Barr virus infection
113262259 (CASP3)
05165 Human papillomavirus infection
113262259 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
113262259 (CASP3)
05133 Pertussis
113262259 (CASP3)
05134 Legionellosis
113262259 (CASP3)
05152 Tuberculosis
113262259 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
113262259 (CASP3)
05145 Toxoplasmosis
113262259 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
113262259 (CASP3)
05012 Parkinson disease
113262259 (CASP3)
05014 Amyotrophic lateral sclerosis
113262259 (CASP3)
05016 Huntington disease
113262259 (CASP3)
05020 Prion disease
113262259 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
113262259 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
113262259 (CASP3)
05416 Viral myocarditis
113262259 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
113262259 (CASP3)
04932 Non-alcoholic fatty liver disease
113262259 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
113262259 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
113262259 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
uah01002
]
113262259 (CASP3)
Enzymes [BR:
uah01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
113262259 (CASP3)
Peptidases and inhibitors [BR:
uah01002
]
Cysteine peptidases
Family C14: caspase family
113262259 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Peptidase_C14
Motif
Other DBs
NCBI-GeneID:
113262259
NCBI-ProteinID:
XP_026364368
LinkDB
All DBs
Position
Unknown
AA seq
277 aa
AA seq
DB search
MENTEHTVDAKAIKNSETKILHGSKSVDSGMSLDNSYKMDYPEMGLCIIINNKNFHRSTG
MTARSGTDVDAANLRETFTNLKYEVRNKNDLTREEILELMDSVSKEDHSKRSSFVCVLLS
HGDEGIIFGTNGPVDLKKLTGFFRGDYCRSLTGKPKLFIIQACRGTELDCGIETDSGAED
DMACQKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCTMLKLYAHKLEFMHILTRVN
RKVATEFESFSLDSAFHGKKQIPCIVSMLTKELYLYH
NT seq
834 nt
NT seq
+upstream
nt +downstream
nt
atggagaacaccgaacacacagtggatgcaaaagccattaaaaattcagaaacaaagatc
ttacatgggagcaaatcagtggactctggaatgtccttggacaacagttataaaatggat
tatcctgaaatgggtttatgtataataattaataataagaactttcatagaagtactgga
atgaccgctcggtctggtacagatgtagatgcagcaaacctccgggaaacattcacgaac
ttgaagtatgaagtcaggaataaaaatgatctcacacgcgaagaaattttggaattaatg
gacagtgtctctaaagaagatcatagcaaaaggagcagttttgtttgtgtgcttctaagc
catggggatgaaggaataatttttggaacaaatggacctgttgacctgaaaaaattaaca
ggtttcttcagaggggattactgtcgaagtctgactggaaaacccaaacttttcattatt
caggcctgccgaggcacagaactggactgcggtattgagacggacagcggagcagaggac
gacatggcctgtcagaaaataccagttgaagcggacttcttgtatgcctattctacagcc
cctggttactactcatggcgaaattcgaaggacggatcctggttcatccagtcactttgt
acgatgctgaaactgtatgctcacaagcttgagtttatgcacattcttacccgggttaac
cggaaggtagccacagaatttgagtccttctctcttgactctgcttttcatggaaagaaa
cagattccgtgtattgtgtcgatgctcacaaaagaactgtatctttatcactaa
DBGET
integrated database retrieval system